OneSource Speci.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE013P01021
  • NSEID: ONESOURCE
  • BSEID: 544292
INR
1,686.40
14.9 (0.89%)
BSENSE

Dec 05

BSE+NSE Vol: 2.01 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About OneSource Specialty Pharma Ltd stock-summary
stock-summary
OneSource Specialty Pharma Ltd
Small Cap
Pharmaceuticals & Biotechnology
Onesource Specialty Pharma Limited was incorporated as a Private Limited Company, with the name and style of `Inbiopro Solutions Private Limited' dated June 12, 2007, was issued by the Registrar of Companies, Karnataka at Bangalore. The Company name was then changed to `Stelis Biopharma Private Limited', pursuant to a Scheme of Amalgamation and a Certificate of Incorporation dated December 24, 2014, was issued by the Registrar of Companies.
Company Coordinates stock-summary
Icon
No Company Details Available
stock-summary Capital Structure
Capital Structure stock-summary
Present Equity Capital
INR None Cr
Number of Shares
None Cr
Face Value
INR None
Date
Number
of Shares(Cr)
Equity
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Non Institution

Pledged Promoter Holdings

26.0357

Mutual Funds

Held by 21 Schemes (8.99%)

FIIs

Held by 163 FIIs (19.39%)

Promoter with highest holding

Tenshi Pharmaceuticals Private Limited (17.92%)

Highest Public shareholder

Authum Investment And Infrastructure Limited (5.2%)

Individual Investors Holdings

12.42%

stock-summary Board of Directorsstock-summary
stock-summary
Management
Designation
Remuneration
stock-recommendationRaw Materials
Raw Materials Dashboard stock-summary
Raw Materials
Amount(Rs Cr)
% of RM Cost
Cost of Materials Consumed
405.572
0%
 
100
Cost of Materials Consumed
stock-recommendation Finished Goods
Finished Goods Dashboard stock-summary
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
 
Icon
No Data Available
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
376 Cr
(Quarterly Results - Sep 2025)
Net Profit:
10 Cr
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

INR 18,971 Cr (Small Cap)

stock-summary
P/E

134.00

stock-summary
Industry P/E

34

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.19

stock-summary
Return on Equity

2.44%

stock-summary
Price to Book

3.23